News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 145–180
- Matches
- 9800
- Sources here
- 20
- Companies here
- 31
Search results
Stored financial headlines
Active search
9800 matching headlines
Ticker or company: RYMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
How Investors May Respond To BioCryst (BCRX) Profit Swing, Raised Revenue Outlook And New ESOP Shares
BioCryst Pharmaceuticals reported a significant profit swing in Q2 2026, with revenue of US$218.25 million and net income of US$78.4 million, prompting a raised full-year revenue outlook to US$690 million–US$715 million. Despite this strong quarter, the company still faces a substantial year-to-date net loss …
BCRX
main company
Sharemaestro market context
Trend signal active
52 weeks +13.8%
Wall Street Zen Downgrades WeRide (NASDAQ:WRD) to Sell
Wall Street Zen has downgraded WeRide (NASDAQ:WRD) from a "hold" to a "sell" rating, despite the stock maintaining a consensus "Moderate Buy" rating with an average analyst price target of $12.32. The company's shares opened at $5.85, close to its 52-week low, and it …
WRD
main company
Sharemaestro market context
Price below Trend Line
52 weeks -38.6%
Aimei Health Technology Co., Ltd Revenue Breakdown – NASDAQ:AFJK
This article provides a revenue breakdown for Aimei Health Technology Co., Ltd (NASDAQ:AFJK) on TradingView. It offers an overview of the company's financials, including statements, statistics, dividends, earnings, and segments. The page also indicates that segment and regional performance data are available by source …
AFJK
main company
Sharemaestro market context
Price below Trend Line
52 weeks +8.4% · Next-week setup positive 63.6%
Mizuho Securities Maintains Bending Spoons S.p.A(BSP.US) With Buy Rating, Cuts Target Price to $72
Mizuho Securities has reiterated its Buy rating on Bending Spoons S.p.A (BSP.US) but has lowered its target price to $72. This indicates a continued positive outlook on the company despite a revised valuation.
BSP
main company
Sharemaestro market context
Stored weekly price path
7 weeks +9.4% · Next-week setup positive 61.7%
Xsolla SPAC 1 (XSLL) earns $2.8M on trust assets, flags control weakness
Xsolla SPAC 1 (XSLL) reported a net income of $2.75 million for the six months ended June 30, 2026, primarily from interest earned on its Trust Account investments. The blank-check company, which is still seeking a business combination, ended the quarter with over $207 …
XSLL
main company
Sharemaestro market context
Stored weekly price path
22 weeks +1.7%
Berto Acquisition Corp. II Releases Q2 2026 10-Q Reporting Post-IPO Financials and Trust Account Status
Berto Acquisition Corp. II (NASDAQ:GUAC) has released its Q2 2026 10-Q report, detailing post-IPO financials and the status of its trust account. The company reported a trust account funded with $315.1 million, with investments totaling over $316.4 million, and a net income of $1.06 …
Sharemaestro market context Trend signal active 52 weeks +1.3%Berto Acquisition Corp. Announces Q2 2026 Financial Results and Trust Account Growth
Berto Acquisition Corp. (NASDAQ: TACO) reported its Q2 2026 financial results, showing an increase in its Trust Account balance to over $314 million. The company recorded a net income of $1.11 million for Q2 2026, primarily driven by investment income from its Trust Account, …
TACO
main company
Sharemaestro market context
Trend signal active
52 weeks +1.3%
Amanat Acquisition Corp. (AMAN): ADAR1 Capital discloses 9.6% ownership stake
ADAR1 Capital Management, LLC and Daniel Schneeberger have reported a beneficial ownership stake of 9.6% in Amanat Acquisition Corp. (AMAN). This ownership, consisting of 750,000 Class A ordinary shares, is held through private investment funds managed by ADAR1 Capital Management, with both entities sharing …
AMAN
main company
Sharemaestro market context
Stored weekly price path
13 weeks +3.5% · Next-week setup negative 44.4%
Krystal Biotech(KRYS.US) Director Sells US$8.23 Million in Common Stock
Krystal Biotech (KRYS.US) Director, Daniel Meyer, sold 84,200 shares of common stock on August 13, 2026, for a total of $8.23 million. The shares were sold at an average price of $97.75. Following this transaction, Meyer directly owns 10,000 shares of the company.
KRYS
main company
Sharemaestro market context
Trend signal active
52 weeks +120.8%
Marex Group Ltd SEC Filing (Aug 14, 2026)
This article details a Marex Group Ltd (MRX) SEC Form 144 filing from August 14, 2026. The filing indicates a proposed sale of 3700 shares of common stock, acquired as compensation in May 2025, with an aggregate market value of $262,922. Goldman Sachs & …
MRX
main company
Sharemaestro market context
Trend signal active
52 weeks +100.4% · Next-week setup positive 55.8%
Pony AI (PONY) Plans 2,000 Robotaxis Across Europe And The Middle East
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Pony AI (NasdaqGS:PONY) agreed to expand its partnership with Uber to deploy over 2,000 robotaxis across Europe and the Middle East. The rollout will …
PONY
main company
Sharemaestro market context
Price below Trend Line
52 weeks -45.0%
Rezolve AI’s New Provenance Platform Could Be A Game Changer For Rezolve AI (RZLV)
Rezolve AI recently launched Rezolve Provenance, a platform designed to mark, sign, and verify AI-generated content, targeting new EU AI Act transparency rules. This compliance-focused tool is expected to support enterprise AI commerce adoption and reinforce Rezolve AI's existing "trust stack" of AI solutions. …
RZLV
main company
Sharemaestro market context
New activity signal
52 weeks -12.7%
Discovery Silver Corp Earnings Call Signals Aggressive Growth
Key Points Interested in Discovery Silver Corp.? Here are five stocks we like better. Record quarterly performance: Discovery Silver produced 67,300 ounces of gold, up 12% sequentially, while revenue rose 12% to $319 million. Adjusted earnings increased to $92.3 million, or $0.11 per share. …
DSV
main company
Sharemaestro market context
Price above Trend Line
52 weeks +185.2%
Discipline and Rules-Based Execution in BCRX Response
This article provides an AI-driven analysis for Biocryst Pharmaceuticals Inc. (BCRX), highlighting strong sentiment, a mid-channel oscillation pattern, and an exceptional risk-reward setup targeting a 15.0% gain. It details three distinct institutional trading strategies—Position, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis for …
BCRX
main company
Sharemaestro market context
Trend signal active
52 weeks +13.8%